Vitara Biomedical Raises $50M in Additional Financing
Summary
The company intends to use the funds to further advance its efforts leading to a first in human clinical study of their technology. Vitara Biomedical is developing a special life support system designed to improve outcomes for babies born prematurely. The company, which is pursuing a first in human clinical study of the Vitara System, also announced the appointment of Kim Rodriguez, an experienced global healthcare and medical device industry professional, as Chief Executive Officer. She has 25 years of experience, spanning multiple therapeutic areas, including neurology, cardiology, and women’s health, most recently as CEO of BrainCheck, a digital health company supporting early identification of dementia and Alzheimer’s disease. Previously she served as CEO & Co-Founder of Acessa Health (acquired By Hologic), CEO at Halt Medical, led the largest business unit at Spectranetics (acquired by Royal Philips) and Johnson & Johnson.